Pradaxa (dabigatran etexilate mesylate) is an anticoagulant. It treats patients with atrial fibrillation (AF) by keeping blood from clotting. The FDA is investigating reports in patients treated with Pradaxa® with uncontrollable bleeding. In December 2011, the FDA made a Safety Announcement, “At this time, FDA continues to believe that Pradaxa® provides an important health benefit when used as directed.” However, there are still public health officials concerned about the rise in Pradaxa®-related internal bleeding and deaths.
There is no reversal agent for it. There are no drugs today which can stop internal bleeding. This causes hemorrhaging until coma, organ damage, and/or death occur.
In fact, are several reports of deaths due to Pradaxa® treatment. For example, an elderly Utah man who had a minor fall in February 2012. Doctors found his brain bleeding uncontrollably. The man’s treatment of Pradaxa® made efforts to stop the bleeding ineffective, resulting in his death.
.
We represent people harmed by medications and can help you and your family pursue damages. Contact The Law Offices of L. Clayton Burgess Today!
